EPG Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,259
Closed -$506K 443
2023
Q3
$506K Buy
15,259
+30
+0.2% +$1.06K 0.15% 147
2023
Q2
$559K Sell
15,229
-976
-6% -$38K 0.17% 137
2023
Q1
$661K Buy
16,205
+2,098
+15% +$90.6K 0.21% 113
2022
Q4
$723K Sell
14,107
-996
-7% -$47.8K 0.28% 83
2022
Q3
$661K Buy
15,103
+491
+3% +$23.9K 0.27% 84
2022
Q2
$766K Buy
14,612
+79
+0.5% +$4.03K 0.33% 72
2022
Q1
$752K Buy
14,533
+2,151
+17% +$112K 0.26% 79
2021
Q4
$731K Buy
12,382
+664
+6% +$32.9K 0.26% 77
2021
Q3
$504K Buy
11,718
+2,034
+21% +$90.1K 0.2% 105
2021
Q2
$379K Buy
9,684
+46
+0.5% +$1.79K 0.16% 130
2021
Q1
$349K Buy
9,638
+433
+5% +$15.4K 0.17% 123
2020
Q4
$339K Buy
+9,205
New +$338K 0.2% 100
2020
Q2
Sell
-6,273
Closed -$194K 585
2020
Q1
$194K Buy
6,273
+3,878
+162% +$132K 0.14% 125
2019
Q4
$89K Buy
+2,395
New +$85.3K 0.07% 165

Other funds holding PFE

EPG Wealth Management's PFE Position: Q4 2023 in Review

EPG Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 15,259 shares — an estimated $506K sold.

EPG Wealth Management first reported a position in PFE in Q4 2019 and held it in 14 quarters. The position peaked at $766K in Q2 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • EPG Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • EPG Wealth Management sold 15,259 Pfizer shares in Q4 2023, an estimated $506K.
  • EPG Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 14 quarters.
  • EPG Wealth Management's Pfizer position peaked at $766K in Q2 2022.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on EPG Wealth Management's 13F filing for Q4 2023, filed 15 Feb 2024.